Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway ; volume:13 ; number:1 ; day:3 ; month:6 ; year:2022 ; pages:1-16 ; date:12.2022
Stem cell research & therapy ; 13, Heft 1 (3.6.2022), 1-16, 12.2022
- Urheber
-
Takao, Tomoka
Masuda, Hirotaka
Kajitani, Takashi
Miki, Fumie
Miyazaki, Kaoru
Yoshimasa, Yushi
Katakura, Satomi
Tomisato, Shoko
Uchida, Sayaka
Uchida, Hiroshi
Tanaka, Mamoru
Maruyama, Tetsuo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-022-02888-y
- URN
-
urn:nbn:de:101:1-2022080222121330943103
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takao, Tomoka
- Masuda, Hirotaka
- Kajitani, Takashi
- Miki, Fumie
- Miyazaki, Kaoru
- Yoshimasa, Yushi
- Katakura, Satomi
- Tomisato, Shoko
- Uchida, Sayaka
- Uchida, Hiroshi
- Tanaka, Mamoru
- Maruyama, Tetsuo
- SpringerLink (Online service)
Ähnliche Objekte (12)
DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway
IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
The role of oncogenic B-Raf in different aspects of malignant transformation
BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition
DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway
IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
The role of oncogenic B-Raf in different aspects of malignant transformation
BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition
DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway
IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
The role of oncogenic B-Raf in different aspects of malignant transformation
BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition